Autres langues CorMedix Inc.

Actions

CRMD

US21900C3088

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
5,37 ^USD	-2,72%		+3,47%	+42,82%

15/04	CorMedix Inc. annonce la disponibilité commerciale aux États-Unis de DefenCath® ? (Taurolidine et héparine)	CI
08/04	Mise à jour sectorielle : Les actions du secteur de la santé déclinent en fin d'après-midi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CORMEDIX INC. ANNOUNCES CMS GRANTS TDAPA TO DEFENCATH	22/04
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath	19/04
CORMEDIX INC. ANNOUNCES U.S. INPATIENT COMMERCIAL AVAILABILITY OF DEFENCATH	16/04
CorMedix's DefenCath Now Commercially Available For US Inpatient Use	15/04
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)	15/04
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin)	15/04
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference	11/04
Sector Update: Health Care Stocks Decline Late Afternoon	08/04
CorMedix to Supply to DefenCath to Florida-based Dialysis Organization	08/04
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC	08/04
CorMedix Inc. Announces Commercial Agreement with ARC Dialysis, LLC	08/04
CorMedix Inc. to Present at the Needham Annual Healthcare Conference	27/03
Sector Update: Health Care Stocks Ease Wednesday Afternoon	13/03
CorMedix Remains Encouraged on DefenCath Opportunity, RBC Says	13/03
CorMedix: Q4 Earnings Snapshot	12/03
CorMedix Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	12/03
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	12/03
CorMedix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
North American Morning Briefing : Inflation Data -2-	12/03
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024	06/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CorMedix Inc.

Actions

CRMD

US21900C3088

Autres langues

Filtres